Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Invested Capital (2019 - 2021)

Historic Return on Invested Capital for Neurocrine Biosciences (NBIX) over the last 3 years, with Q3 2021 value amounting to 0.05%.

  • Neurocrine Biosciences' Return on Invested Capital fell 500.0% to 0.05% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.05%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.05% for FY2019, which is 200.0% up from last year.
  • As of Q3 2021, Neurocrine Biosciences' Return on Invested Capital stood at 0.05%, which was down 500.0% from 0.09% recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Return on Invested Capital peaked at 0.21% during Q2 2020, and registered a low of 0.05% during Q3 2021.
  • For the 3-year period, Neurocrine Biosciences' Return on Invested Capital averaged around 0.11%, with its median value being 0.1% (2020).
  • Over the last 5 years, Neurocrine Biosciences' Return on Invested Capital had its largest YoY gain of -500bps in 2021, and its largest YoY loss of -1200bps in 2021.
  • Over the past 3 years, Neurocrine Biosciences' Return on Invested Capital (Quarter) stood at 0.05% in 2019, then soared by 99bps to 0.1% in 2020, then plummeted by -52bps to 0.05% in 2021.
  • Its Return on Invested Capital was 0.05% in Q3 2021, compared to 0.09% in Q2 2021 and 0.1% in Q1 2021.